# PATHOVAX LLC: Form D filing

PATHOVAX LLC, a biotechnology company in Baltimore, MD, filed a Form D with the SEC in 2018. The latest, on August 31, 2018, reports $2.8 million sold of a $2.8 million offering to 2 investors.

Find out what PATHOVAX LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PATHOVAX%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PATHOVAX%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fpathovax-llc-1744237)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PATHOVAX%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PATHOVAX%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fpathovax-llc-1744237)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1812 ASHLAND AVENUE, STE 100, Baltimore, MD, 21205
- Phone: (443) 449-8836
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Maryland
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1744237

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 31, 2018 | New notice | $2,750,000 | $2,750,000 | $0 | 2 | May 10, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1744237/000101410018000051/0001014100-18-000051-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Weijie Weiyuan Poh | Director, Promoter |  |
| Joshua Weiyuan Wang | Director, Promoter |  |

## Other biotechnology companies in Maryland that filed recently

- [BlueHealer Inc.](https://specstream.ai/data/form-d/company/bluehealer-inc-2162934) $1 · Nov 4, 2026
- [Accufy Diagnostics, Inc.](https://specstream.ai/data/form-d/company/accufy-diagnostics-inc-2089723) $2 million · Oct 28, 2026
- [OS Therapies Inc](https://specstream.ai/data/form-d/company/os-therapies-inc-1795091) $7.2 million · Oct 23, 2026
- [Kaigene, Inc.](https://specstream.ai/data/form-d/company/kaigene-inc-1919055) $55 million · Oct 14, 2026
- [Templar Nova, Inc.](https://specstream.ai/data/form-d/company/templar-nova-inc-2158642) $7 million · Oct 7, 2026
- [Monocacy Therapeutics Inc.](https://specstream.ai/data/form-d/company/monocacy-therapeutics-inc-2137361) $25,000 · Oct 7, 2026

[Every Form D from the week of Aug 27, 2018](https://specstream.ai/data/form-d/week/2018-08-27) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PATHOVAX LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).